hematoxylin and eosin or methyl green-pyronine. Smears of lymph nodes and femoral bone marrow were also taken and stained with Wright's stain.
OBSERVATIONS

Effects of a Single Subcutaneous Dose of ALS or NRS.--Hematologic changes:
Anemia was a constant feature in animals given a single dose of unabsorbed ALS; a fall in hematocrit of 10% or more was observed within 48 hr after injection and persisted for 1 wk or longer. Prior absorption of the antiserum with mouse erythrocytes ameliorated or abolished the anemia.
A marked drop in both circulating granulocytes and lymphocytes was observed within 6 hr of injection. Absolute lymphocyte levels remained profoundiy depressed to 10-20 % of normal for 48 hr, and continued to remain somewhat below normal levels for 2 wk or longer (Fig. 1 a) . Antiserum absorbed with mouse red cells retained the ability to induce lymphopeula.
Anemia or lymphopenia were not seen 2 days after a single dose of normal rabbit serum; rather, a distinct lymphocytosis was seen on the 6th day postinjection.
Abundant platelets were present in peripheral blood smears taken from both ALS and NRS-treated animals. An abnormal bleeding tendency was never observed in this group.
Lymph nodes: Within the first 48 hr after ALS injection, focal accumulations of cellular debris and pyknotic nuclei could be detected in the small vessels of the loose cortex or paracortical regions of lymph nodes draining the injection site (right axillary), as well as more distant lymph nodes (Fig. 7) .
By 48 hr a striking depletion of small lymphocytes was noted in both ipsiand contralateral axillary, brachial, and inguinal nodes, and to a lesser extent in mesenteric nodes; this depletion was sharply confined to the paracortical region. A few small lymphocytes remained, closely associated with postcapillary yentiles, but the contents of this region consisted for the most part of reticulum cells, large lymphocytes, and immunoblasts (Fig. 3) .
By 96 hr, lymphocytes began to reappear in this area, but significant depletion remained for 1 wk or longer after some antisera. By this time, also, increased numbers of immunoblasts and reticulum cells could be seen in the cortex and paracortical area. Moreover, a pronounced medullary hyperplasia with the production of plasma cell precursors was in evidence.
Between 4 and 10 days after injection, the medullary hyperplasia increased, and plasma cells appeared in large numbers within medullary sinusoids. Germinal follicles appeared in some axillary nodes (Fig. 5) .
Animals treated with a single dose of normal rabbit serum showed no lymphocyte depletion. Between 4 and 10 days after injection, medullary hypertrophy, germinal center formation, and plasmacytosis were noted. These changes were slightly less intense than in ALS-treated animals (Figs. 4 and 6) .
In both ALS-and NRS-treated animals, the weight of peripheral (axillary) 
~ o
lymph nodes increased for 6 days after injection, and approached normal by 10 days (Fig. lb) .
Spleen: By 48 hr after a single dose of ALS, there was usually a slight increase in spleen weight due to hyperplasia of the red pulp with increased myeloid and erythroid precursor cells. This hyperplasia could be lessened but was not abolished by prior absorption of the antiserum with mouse red cells. By 96 hr after injection, occasional follicles showed mild depletion of small lymphocytes from periarteriolar areas; this was neither striking nor uniform.
NRS-treated animals showed neither increased splenic erythropoiesis nor lymphoid depletion.
In both ALS-and NRS-treated animals, a moderate follicular hyperplasia of immunoblasts and plasma ceils occurred between the 4th and 10th postinjection day, accompanied by a gradual increase in spleen weight (Fig. lb) . This had begun to recede at 2 wk postinjection.
Peyer's patch: No lymphoid depletion was seen after ALS. However, many necrotic lymphocytes could be seen within small vessels at 24 and 48 hr after a single dose of ALS (Fig. 8 ).
Bone marrow: Neither ALS-nor NRS-treated animals showed any consistent change from the usual predominance of myeloid cells. No definite decrease in marrow small lymphocytes was detected in either group.
Thymus: A drop of 10-15 % in thymus weight was occasionally noted 4 days or more after a single dose of ALS; no other abnormalities in either thymic architecture or cellularity were noted after a single dose of ALS or NRS. In the ALS-treated animals, the thymus appeared normal despite striking small lymphocyte depletion in other organs (Fig. 9) .
Li~er, lungs, adrenals, heart, kidneys, and brain were iudged grossly and microscopically normal after either ALS or NRS.
Effects of a Short Course of ALS or NRS.--Hematologic changes:
Anemia usually had corrected itself by one or 2 wk after the last dose of a course of antiserum, whether the course consisted of 1, 2, or 3 doses of 0.5 ml. Likewise, lymphocyte counts had reached normal levels by 4 wk after the last injection, whether one, two or three doses of ALS were given initially (Fig. 2) . Occasionally, large transitional lymphocytes with basophilic cytoplasm could be seen in peripheral blood smears from either ALS-or NRS-treated animals. No platelet abnormalities were seen in either group.
Lymph nodes: Paracortical depletion, noted after a single close of ALS, was well established 24 hr after the last of three doses of ALS; it tended to persist for longer periods, being noticeable 2 wk or more after the last dose.
Lymph nodes were grossly enlarged after a short course of either ALS or NRS, because of intense medullary hyperplasia and germinal center formation. The greatly expanded medulla tended to encroach upon and obscure the boundaries of the paracortical region, so that ALS-induced lymphoid depletion could often not be detected in routine hematoxylin and eosin-stained material. Lymphoid depletion could be easily discerned, however, in sections stained with methyl green-pyronine.
Spleen: Mter three doses of ALS, the spleen showed striking depletion of small lymphocytes from the periarteriolar regions of all lymphoid follicles; this persisted longer than 2 wk (Fig. 10) . In this markedly depleted area, a rim of Recovery of lymphocyte levels after one, two, or three doses of 0.5 ml ALS given at 2-day intervals. Each point represents the mean of determinations of lymphocyte count of 3 or 4 animals. Recovery to initial lymphocyte levels was not complete until 4-5 wk after injection, whether one, two, or three doses had been given.
immunoblasts could be made out surrounding the central arteriole (Fig. 11) . No such lesions were observed in NRS-treated animals.
The spleens from both ALS-and NRS-treated animals were enlarged, with generalized follicular hyperplasia with immunoblasts and plasma cells within and at the edge of follicles. Moderate erythroid hyperplasia of the red pulp was present, more intense in the ALS-treated animals.
Bone marrow: Mter three doses of ALS, moderate erythroid hyperplasia was usually seen in marrow sections and smears. Small lymphocytes were present, although their numbers were somewhat reduced. NRS-treated animals showed no changes in the bone marrow.
The thymus, adrenals, kidneys, liver, lungs, and heart were all morphologically within normal limits. The absence of either thymic or adrenal atrophy in these animals seems noteworthy.
Skin grafts: The evolution of the homograft reaction was studied in animals that received 0.5 ml of ALS 2 and 5 days after being grafted with A strain tail skin.
In both normal and ALS-treated animals, infiltration of the graft bed with lymphocytes and plasma cells was noticeable by the 5th day after grafting. In untreated animals, this increased until by day -{-10 the graft was edematous and heavily infiltrated, and showed degeneration of dermal appendage structures; epidermal necrosis invariably occurred by day +12 (Fig. 12) .
In the ALS-treated animals, the infiltrate was very sparse, and failed to evolve with the characteristic intensity or perifollicular distribution seen in the usual homograft response. By day 10, only a few lymphocytes and plasma cells were present throughout the basal layers of the dermis, with little tendency to aggregate around hair follicles. Grafts examined at the 14th day (3 days after the median rejection time in untreated recipients) appeared grossly normal, with intact epidermis and no induration. Microscopically, the infiltrate had receded (Fig. 13) . Grafts which rejected after 20 to 25 days showed a rapid and heavy accumulation of mononuclear cells in all layers of the dermis and surrounding hair follicles.
Effects of Chronic Treatment with ALS or NRS.--Mice treated for 3-6 months with weekly maintenance doses of ALS or NRS maintained a weight of 26-30 g, and showed no evidence of wasting, overt infections, or tumor formation. This regimen of ALS treatment prolonged (180 days or longer) the survival of skin homografts as long as it was continued (16) . Deaths in the chronic treatment group sometimes occurred within a few hours after a serum injection, presumably due to anaphylaxis. After 3 months of treatment, additional mortality was noted and attributed to renal disease (see below under Kidney) (Table I) .
Hematologic ,ffects: Anemia was present in all animals treated with ALS throughout the period of treatment; hematocrits generally remained stable at 25-30 %. Lymphopenia was a constant feature with lymphocyte values stabilizing at about one-half the normal absolute value; recovery time of the normal lymphocyte number was delayed for at least 1 month after ALS was discontinued. Platelets were present in all blood smears examined; no bleeding tendencies were noted.
Lymph nodes: Striking paracortical depletion was uniformly present in ALStreated animals after discontinuing ALS; significant depletion was present as long as 1 month later. The cortex appeared intact; as a rule, well-developed germinal centers were noted. Some lymph nodes showed loci of cortical fibrosis after prolonged treatment.
In animals treated chronically with either ALS or NRS, there was striking medullary hyperplasia with sheets of plasma cells and many eosinophils overrunning the medullary sinusoids.
The bone marrow showed marked to moderate erythroid hyperplasia throughout the period of chronic ALS treatment.
The thymus was histologically normal after 6 months of treatment with either ALS or NRS. Thymic cortical depletion was noted in several animals who developed severe renal disease as a result of treatment with either ALS or NRS.
The liver, lungs, keart, adrenals, and brain were all within normal histological limits in both ALS-and NRS-treated groups.
Skin grafts were tolerated for prolonged periods in the ALS-treated group.
These showed findings similar to those described after a short course of ALS. With continued treatment, most grafts showed no microscopic evidence of infiltration at all after 3 months of treatment. The lymph node draining a viable graft at the end of 8 wk of chronic ALS treatment showed a combination of marked germinal center formation and moderate paracortical depletion; in some cases the demarcation d the paracortical areas was obscured by hyperplasia of the adjacent medullary region (Fig. 14) .
Kidneys: After 3 months of weekly treatment with 0.25 ml of either ALS or NRS, most animals developed histologlc evidence of nephritis, with fibrinoid accumulations within glomeruli and thickening of Bowman's capsule, similar to lesions seen in serum sickness nephritis (Fig. 15) . Immunofluorescent stains were negative for rabbit g~mma globulin, but markedly positive for mouse gamma globulin, tending to confirm this impression. The nephritic changes in many animals seemed sufficiently advanced to account for the constitutional effects of wasting, ascites, pleural effusion, and death seen in a portion of animals treated with either ALS or NRS.
Effects of the Purified Gamma Globulin (IgG) Fraction of ALS or NRS.--The
histological effects of a single dose of ALS IgG were entirely similar to those produced by whole antiserum. Lymphopenia was observed after 6 hr, and marked paracortical depletion after 48 hr. By 6 days, there was some depletion of the paracortical areas and vigorous medullary hyperplasia.
Animals given a single dose of NRS IgG developed neither lymphopenia nor lymphoid depletion, but did develop moderate medullary hyperplasia.
To determine if the depletion of lymphocytes observed after ALS was related to the immunogenicity of ALS IgG (19), a single dose of ALS IgG was administered to recipients 3 wk after they had received a dose of NRS IgG sufficient to induce paralysis. In these animals, lymphoid depletion proceeded as in nonparalyzed recipients. However, less medullary hyperplasia was seen in these animals than in animals given ALS IgG without prior paralysis.
Toxic Effects of Antisera Manufactured Using Adjuvants.--Some antisera
were prepared by inoculating donor rabbits with suspensions of routine thymocytes incorporated into adjuvants such as aluminium phosphate or Arquad-2-HT (15). These antisera were highly toxic to recipient mice and required extensive absorption with both red ceils and minced tissues before use. Mice given 0.5 ml of one such antiserum without previous absorption (serum 33) died within 10 days with wasting, hunched posture, and milled fur.
Numerous pathological lesions were seen in these mice which had no counterpart in those animals given ALS prepared by our routine method. These included: thymic involution with pronounced depletion of cortical thymocytes; cortical as well as paracortical depletion of lymphocytes from lymph nodes; extreme erythroid hyperplasia with four4old splenomegaly and hepatic foci of extramedullary hematopoiesis; and numerous 0.2-0.5 mm liver microabscesses (Fig. 16 ).
Histologic Effects of Miscdlaneou~ Antisera.--Horse anti--mouse lympkocyte globulin: Lymph nodes from recipients of this immunosuppressively weak antiserum showed mild to moderate paracortical depletion of lymphocytes 48 hr after injection, less pronounced than in animals treated with routine rabbit ALS. By the 6th day after injection, there was intense medullary hyperplasia which completely obscured the boundaries of the paracortical areas.
Duck anti-mouse lymphocyte serum: This antiserum, which was completely ineffective as an immunosuppressant, produced no lymphoid depletion at any time after a single dose. By the 6th postinjection day, some hyperplasia of the medulla was in evidence.
Toxic Effects of High Dose Intravenous ALS.--50 % of recipients given 1.0 ml whole unabsorbed ALS by intravenous injection succumbed within 48 hr. At the time of death, all animals showed hemoglobinemia and hemoglobinuria; there was massive hemorrhage from the gastrointestinal tract. Obvious infarcts were present in liver, kidneys, and lungs. Lymphoid fisses showed paracortical and perifoUicular depletion, although the thymus did not appear significantly affected.
DISCUSSION
In order to classify better the histological changes which develop after ALS treatment, it is convenient to regard the whole unabsorbed antiserum as a mixture of three categories of substances (a, b, c) : (a) consists only of that fraction of ALS which is immunosuppressively active, contained within the small fraction (3-5 %) of ALS IgG molecules directed specifically against lymphocyte antigens (17, 32, 33) ; (b) consists of other rabbit anti-mouse antibodies, either IgG or IgM, irrelevant to the immtmosuppressive activity of ALS, but potentially or actively toxic to the mouse; and (c) is a category to which we may assign all other rabbit serum components, non-gamma globulins as well as gamma glob-lln~, which may be immunogenic in mice.
Each category of substances gives rise to a distinctive histologic picture; under the usual conditions of ALS administration all three types of histological changes could occur simultaneously.
Lesions Due to the Immunosuppressive Fraction of ALS.--A consistent pattern of histologic changes was specifically associated with the immunosuppressive capacity of antilymphocytic antiserum. This consisted of peripheral lymphopenia occurring at 48 hr after the first injection of antiserum, selective depletion of small lymphocytes from lymph nodes, paracortical areas and splenic follicular periarteriolar regions, and relative preservation of thymic architecture. All animals bearing skin grafts under the aegis of ALS, whether for 20 or 150 days, showed signs of paracortical and periarteriolar lymphocyte depletion; antisera which were weakly immunosuppressive, such as HALGG, showed a lesser depletive effect. Duck anti-mouse antiserum, totally ineffective at prolonging skin homografts (15) seemed incapable of producing such depletion. Other histologic features of ALS administration discussed more fully below, such as hemolytic anemia or hyperplasia of lymphoid organs, seemed irrelevant to the immunosuppressive effect and could occur in its absence.
Lymph node changes similar to those we have observed have been described previously by other workers (27, 31) , and we concur with them in suggesting that this depletion is one characteristic accompaniment of immunosuppression of transplantation immunity by antilymphocyte serum. Although extensive depletion of the cortical as well as the paracortical area has been achieved with intensive treatment with ALS (8) it appears from our studies that paracortical depletion alone is sufficient to procure indefinitely prolonged immunosuppression.
It seems likely that a rapid depletion of lymphocytes is brought about by the lymphocytotoxic action of ALS; the large numbers of pyknotic nuclei which quickly accumulate in lymphoid tissue capillaries after a single dose of ALS, attest to this. Other evidence obtained from in vivo studies of Cr-51-1abeled lymphocytes (30) have established that a single dose of antiserum can destroy a large proportion of such lymphocytes in the recipient.
The restriction of lymphoid tissue depletion to the paracortical and periarteriolar zones is indicative of a preferential action of ALS on the rapidly recirculating lymphocyte pool. These zones, which consist largely of long-lived recirculating cells, can be selectively depleted after maneuvers such as prolonged thoracic duct cannulation (22) , extracorporeal irradiation of the blood (4), and neonatal thymectomy (26) . Levey and Medawar (21) suggested that ALS acts in the first instance on peripheral lymphocytes. Our previous observations (30) on the distribution of radioactively-labeled lymphocytes in ALS-treated recipients indicated that ALS removed lymphocytes from that portion of the rapidly recirculating pool of cells that is external to lymph nodes, and that labeled lymphocytes which had already "homed" to lymphoid organs were relatively impervious to the action of ALS. In further support of this view, we have determined by radioautographic studies of lymphoid tissues of ALS-treated mice peffused with intravenous tritiated thymidine, that ALS treatment results in a selective and extensive removal of long-lived small lymphocytes from lymph node paracortical areas (29) . Moreover, it has been determined that fluorescein-labeled antilymphocyte globulin penetrated lymphoid tissues poorly (5) .
The thymus appeared histologically normal in the vast majority of animals given repeated doses of routine ALS. It seems unlikely that a direct effect on either thymocytes or thymic "humoral factor" is operative in producing the specific histologic accompaniments of immunosuppression by ALS. This does not exclude that a portion of the immunosuppressive action of ALS may be mediated through the thymus, as has been suggested by some workers (27, 28) . The fact that the characteristic lesions are found in those areas of lymphoid tissue designated as "thymus-dependent" (26) implies to us only that these areas reflect the state of the total recirculating lymphocyte compartment with which they are in equilibrium.
The histological course of skin allograft rejection under ALS treatment is of interest. The tendency of lymphoid infiltration to decrease and finally disappear after chronic, prolonged treatment may herald a state resembling specific tolerance in a portion of chronically treated, skin-allografted animals. Recent observations have indicated that ALS treatment when combined with thymectomy (24) or administration of additional antigen 1 may predispose to the acquisition of specific immunological tolerance.
Lesions Due to "Irrdevant" Antibodies.--Medawar (23) has pointed out that ALS must consist of a mixture of antibodies directed against numerous cellular antigens, most of which are irrelevant to its desired immunosuppressive activity. Among the identified but irrelevant antibodies which may be generated concomitantly with ALS are included 7S and 19S hemagglutinins and hemolysins (1), 19S anti-leukocyte activity (13) , and anti-mouse gamma globulins (8) ; none of these has the capacity to prolong skin allograft survival.
It is surprising that more in the way of side effects due to irrelevant antibodies did not occur in our experimental animals. The most prominent toxic effect produced was that of hemolytic anemia, in severe instances accompanied by hemoglobinemia and hemoglobinuria. Bone marrow and splenic erythroid hyperplasia occurred after treatment even with ALS that had been absorbed with red cells, although no anemia developed, making it likely that even absorbed ALS possesses some, albeit controllable anti-red cell activity.
Antisera manufactured with the use of aluminium phosphate or Arquar incorporated into the immunizing cell suspensions were considerably more toxic than routinely prepared sera, and it is possible that adjuvant immunization increased the amount of irrelevant antibodies present. Apart from an intense hemolytic anemia, accompanied by extreme erythroid metaplasia in the spleen, marrow, and even the liver, widespread and variegated lesions were seen in other organs:
The thymus was usually depleted of cortical lymphocytes after two injections of such antiserum. Denman and Frenkel (5) and Lance (17) have determined that ALS does not enter the thymus to any appreciable extent. It thus seems likely to us that this depletion is brought about by a generalized stress response rather than by any direct effect of ALS on thymic tissue. The generalized lymph node depletion seen in these mice also reflects a process qualitatively different from that obtaining with our usual antisera, and one that is unnecessary for allograft prolongation.
The punctate lesions seen in the liver of these animals may represent invasion of pathogens as a result of lowered host resistance, as in the HMV infections 1 Lance, E. M., and P. B. Medawar. Data to be published, described in thymectomized mice (6) . We have not, however, excluded that they are due to a directly toxic effect of the antiserum on liver tissue.
The administration of large intravenous doses of routine ALS results in marked damage to erythrocytes and platelets, and widespread hemorrhages and infarction in many organs. It seems possible that irrelevant and potentially toxic antibodies are usually present in even our routine antiserum, but are absorbed onto tissue receptor sites when the antiserum is injected subcutaneously.
Lesions Due to Immunization by Immunogenic Components of ALS.--In
anlmais given either ALS or NRS, the histologic features of immunization develop. These consist of hypertrophy of lymphoid tissue with pronounced medullary hyperplasia and germinal center formation in lymph nodes, and follicular hyperplasia in spleens. Blast forms and plasma cells are prominent in these regions. In some animals, eosinophilia in peripheral blood and lymph nodes may develop as in genuine serum sickness.
The medullary hyperplasia which occurs in lymph nodes during the period when cellular hypersensitivity has been virtually abolished by ALS treatment is of particular interest. It confirms the unique capacity of ALS to discriminate between humoral and cellular responses, and selectively to suppress the latter, as noted by Lance and Batchelor (18) . It also provides additional evidence that the suppressive effects of ALS are exerted preferentially on that population of cells which mediates cellular immunity. Although several investigators have noted the ability of ALS to transform lymphocytes to immunoblasts in vitro (7, 9, 11, 33) , there is little in our studies to suggest that lymphocyte activation by means other than antigenic stimulation takes place in vivo. Medullary proliferation with blast transformation takes place slightly more vigorously in ALS than NRS-treated animals, doubtless due to the greater immunogenicity of ALS IgG (19) . Previous immunization of animals with N-RS IgG can markedly augment this transformation, while prior paralysis to NRS IgG can significantly inhibit it. It thus seems that these changes are due to an orthodox ~mmune response to rabbit serum constituents, and are not directly relevant to the immunosuppressive action of ALS.
In chronically treated animals, "complex" nephritis may develop as a result of hyperimmunlzation to rabbit serum components. Similar lesions have been noted by others in other species (10, 12) . Lance and Dresser's finding that paralysis of ALS recipients with NRS IgG abolishes a subsequent immune response to purified ALS gamma G (19) may provide a means for circumventing this hazard. Our present findings in animals tolerant of NRS IgG would support this consideration.
SD'M-~r~RY
The effects of heterologous rabbit anti-mouse lymphocyte antiserum on the morphology of lymphoid and other tissues was investigated in CBA mice.
The lymphoid tissues exhibited characteristic changes specific for ALS treatment, which were an invariable accompaniment to its immunosuppressive effects. These consisted of peripheral lymphopenia occurring at some time during a course of ALS treatment and persistent depletion of small lymphocytes in lymph node paracortical areas and splenic follicular periarteriolar zones. The thymic histology was generally weU preserved.
It is suggested that the relevant lesions reflect a rapid depletion of the pool of recirculating lymphocytes, possibly by a primary cytotoxic effect exerted on cells peripheral to lymphoid tissue.
Other histologic features attendant to the administration of ALS were accounted for as consequences of immunization of ALS recipients to rabbit serum constituents or by the deleterious effects of antibodies directed against tissues other than lymphoid cells. A strain graft on CBA recipient that received 0.5 ml ALS on the 2nd and 5th days after grafting. 13 days after grafting, the epidermis is intact with no edema and minimal infiltrate. Hematoxylin and eosin. X 96.
Fio. 14. Axillary lymph node draining a viable A strain skin allograft after 8 wk of chronic ALS treatment. Note paracortical depletion, somewhat obscured in outline by hyperplasia of adjacent medullary tissue. Note formation of germinal centers. Hematoxylin and eosin. × 52. 
